Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Researchers argue that Omicron’s lower severity is a coincidence

by Medical Finance
in Coronavirus
Study: Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity. Image Credit: Fit Ztudio/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent comment published in Nature Reviews Microbiology, researchers raised concern regarding the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with unpredictable severity and immune evasion potential due to its ongoing fast-paced antigenic evolution.

Study: Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity. Image Credit: Fit Ztudio/Shutterstock
Study: Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity. Image Credit: Fit Ztudio/Shutterstock

Lower severity of Omicron could be a coincidence

The high transmissibility, availability of several animal host reservoirs, the phenomenon of waning immunity, and more importantly, antigenic evolution contribute to the continued persistence of SARS-CoV-2 in humans. Accordingly, the researchers argued that SARS-CoV-2 is all set for continuous circulation in humans, and milder infectivity of its new variant of concern (VOC) Omicron could merely be a coincidence.

Predicting the virulence of a pathogen is complex, and typically evolutionary pressure does not select against it. In the case of SARS-CoV-2, although disease severity manifested late in infection, only after its transmission attained a peak, it does not suggest that the lower severity of Omicron is a good predictor for future variants.

Perhaps the prospect of future VOCs featuring the potentially devastating combination of the ability to re-infect due to immune escape along with high virulence is regrettably realistic. The notion that widespread vaccine or infection-induced immunity will eventually result in herd immunity and guarantee milder SARS-CoV-2 infections in the future also seems quite unrealistic from the standpoint of the antigenic evolution of SARS-CoV-2.

As the viral antigenic profile will adapt in response to host immune pressures resulting in immune escape, the immune system will not be able to prevent severe disease. On a population level, it would increase the rates of re-infection and disease severity. Omicron’s rapid emergence remarkably demonstrated how SARS-CoV-2 is capable of considerable antigenic escape over a relatively short period.

Omicron, featuring at least 50 new amino acid mutations, is highly antigenically divergent from the original ancestral Wuhan-Hu-1 strain and other VOCs of SARS-CoV-2. It has rapidly spread and evaded already waning immunity to cause breakthrough infections in vaccinated and previously-infected individuals alike. Omicron’s genetic divergence and functional significance of this divergence were demonstrated by the increasing proportion of its BA.2 lineage.

Evolutionary evidence of antigenic divergence of yet to emerge SARS-CoV-2 variants

Three earlier SARS-CoV-2 VOCs – Beta, Gamma, and Delta – also featured immune escape mutations, and there is no scientific evidence to suggest that this evolution is coming to a halt anytime soon. As per the evolutionary theory, these VOCs are the tip of the ‘evolutionary iceberg.’ Several SARS-CoV-2 lineages, highly divergent from each other and with increased immune evasion capabilities, are ready to emerge over time.

Another fascinating aspect of the antigenic evolution of SARS-CoV-2 is that it is increasingly optimizing its transmissibility (Rt) by refining its ability to re-infect immunized individuals and less via being infectious. Earlier SARS-CoV-2 VOCs were 50% more infectious than their predecessors, including the Alpha and Delta VOCs, as a fitter virus is the one that transmits to the maximum number of hosts, and this was possible only by becoming more infectious. However, it was unfeasible in a highly immune population.

Accordingly, as the human population transitioned to high levels of immunity, SARS-CoV-2 accelerated the rates of antigenic evolution, and Omicron, with its extraordinary ability to re-infect immune individuals, best exemplified this evolutionary strategy.

However, the emergence of a less virulent strain does not imply that the SARS-CoV-2-induced pandemic is approaching its end. Once Omicron infects the majority of individuals, another variant, highly antigenically divergent from Omicron, might emerge as immune escape needs to adapt to continually changing targets.

Although at present, it is impossible to predict the time of emergence or antigenic and viral properties of future SARS-CoV-2 variants, a more infectious VOC would most likely replace Omicron along with the features that contribute to its lower severity. Notably, Omicron preferentially infected the upper respiratory tract (not the lung tissue) and showed a reduced tendency to induce cell-cell fusion.

Intriguingly, molecular clock analysis had predicted the split of Omicron from its predecessors a year before its actual epidemic emergence. Thus, suggesting that other antigenically divergent SARS-CoV-2 variants have already arrived or are currently forming and will soon emerge.

Conclusions

There is an urgent need to dissect the mechanisms, circumstances, and factors contributing to the generation of antigenically divergent SARS-CoV-2 variants. More specifically, it is crucial to examine patterns of antigenic evolution in immune-deficient individuals and animal species residing close to humans, which could be SARS-CoV-2 animal reservoirs. Such understanding will enable a more reliable evaluation of the future burden of coronavirus disease 2019 (COVID-19) in humans and accordingly prepare mitigation and intervention strategies.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Serum extracellular vesicles trace COVID-19 progression and immune responses. Image Credit: Fit Ztudio / Shutterstock.com

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

by Medical Finance
May 28, 2022
0

Over the past several years, considerable effort has been made towards developing better diagnostic and prognostic tools. However, until now,...

Study: NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells. Image Credit: Kateryna Kon/Shutterstock

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

by Medical Finance
May 28, 2022
0

Scientists now understand that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negatively impacts the brain. However, whether the virus travels...

Study: Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers. Image Credit: Matheus Nunes de Oliveira / Shutterstock.com

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

by Medical Finance
May 28, 2022
0

In a recent Journal of Infection and Chemotherapy study, researchers investigate the dynamics of anti-spike immunoglobulin G (IgG) levels against...

Study: Effectiveness of the BNT162b vaccine fourth dose in reducing SARS-CoV-2 infection among healthcare workers in Israel, a multi-center cohort study. Image Credit: Vincent B David/Shutterstock

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

by Medical Finance
May 28, 2022
0

The development and mass administration of several coronavirus disease 2019 (COVID-19) vaccines allowed many nations to vaccinate their population. Still,...

Study: Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands. Image Credit: Maridav/Shutterstock

Studying the immune response after COVID-19 vaccination using smartwatches and fitness bands

by Medical Finance
May 29, 2022
0

The response to vaccination varies among individuals. Some vaccines cause adverse reactions, termed reactogenicity. Vaccine reactogenicity can cause physiological changes....

Genome editing in vascular endothelial cells made possible with a powerful new delivery system

Researchers are in the race to beat Omicron

by Medical Finance
May 28, 2022
0

David Veesler and his lab members aren't getting much sleep these days. In the final weeks of 2021, he and...

Next Post
Grouping tumors by ‘immune archetypes’ points the way to personalized immunotherapies

Novel AI algorithm developed for assessing digital pathology data

Study: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is mediated by a stereotyped clonotypic antibody. Image Credit: Corona Borealis Studio/Shutterstock

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • CRISPR locus on DNA sequence Catalin Rusnac 51742dddb09c41d2924841b1b4decc7a 620x480
    Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure
  • 91618146 620x480
    New chemical reaction creates a faster, simpler way of making tertiary amines for medicines
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply